Clinical data | |
---|---|
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Pregnancy cat. | C(US) |
Legal status | ? |
Routes | Intravenous |
Pharmacokinetic data | |
Protein binding | Nil |
Metabolism | Nil |
Half-life | 80 to 120 minutes |
Excretion | Renal |
Identifiers | |
CAS number | 131069-91-5 |
ATC code | V08CA06 |
PubChem | CID 6435809 |
DrugBank | APRD00993 |
ChemSpider | 392041 |
UNII | RLM74T3Z9D |
KEGG | D01646 |
ChEMBL | CHEMBL1200457 |
Chemical data | |
Formula | C20H34GdN5O10 |
Mol. mass | 661.77 g/mol |
SMILES | eMolecules & PubChem |
|
|
(verify) |
(what is this?)
Gadoversetamide is a gadolinium-based MRI contrast agent, particularly for imaging of the brain, spine and liver.[1] It is marketed under the trade name OptiMARK.